Back
NovoCure Vs. Agios Pharmaceuticals Industry Stock Comparison
Sell
35
NVCR
NovoCure
Last Price:
12.36
Seasonality Move:
12.01%
Sell
40
AGIO
Agios Pharmaceuticals
Last Price:
31.66
Seasonality Move:
0.06%
Sell
35
NovoCure (NVCR)
is a Sell
Is NovoCure a Buy, Sell or Hold?
- The current NovoCure [NVCR] share price is $12.06. The Score for NVCR is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- NVCR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Agios Pharmaceuticals (AGIO)
is a Sell
Is Agios Pharmaceuticals a Buy, Sell or Hold?
- The current Agios Pharmaceuticals [AGIO] share price is $31.81. The Score for AGIO is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- AGIO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NVCR Stock Price Chart
AGIO Stock Price Chart
What is Agios Pharmaceuticals's stock price today?
-
The Agios Pharmaceuticals share price today is $31.81
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AGIO is experiencing slight buying pressure.
NVCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.73 | Sell |
| Relative Strength Index (14 RSI): | 35.71 | Sell |
| Chaikin Money Flow: | -32564 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.51 - 14.67) | Sell |
| Bollinger Bands (100): | (12.92 - 15.44) | Sell |
AGIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.28 | Buy |
| Relative Strength Index (14 RSI): | 65.7 | Buy |
| Chaikin Money Flow: | 93235 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (28.46 - 30.32) | Buy |
| Bollinger Bands (100): | (22.6 - 30.04) | Buy |
NVCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.35 | Sell |
| 20-day SMA: | 13.62 | Sell |
| 50-day SMA: | 14.62 | Sell |
| 200-day SMA: | 18.1 | Sell |
| 8-day EMA: | 12.45 | Sell |
| 20-day EMA: | 13.26 | Sell |
| 50-day EMA: | 14.02 | Sell |
| 200-day EMA: | 22.94 | Sell |
AGIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.7 | Buy |
| 20-day SMA: | 29.23 | Buy |
| 50-day SMA: | 29.71 | Buy |
| 200-day SMA: | 25.5 | Buy |
| 8-day EMA: | 30.01 | Buy |
| 20-day EMA: | 29.61 | Buy |
| 50-day EMA: | 28.78 | Buy |
| 200-day EMA: | 26.36 | Buy |
NovoCure Earnings Growth & NVCR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.01 per share, an increase this year of $0.27 per share, and a decrease next year of $0.08 per share.
Agios Pharmaceuticals Earnings Growth & AGIO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.55 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.69 per share, and a decrease next year of $0.11 per share.
NovoCure Technical Analysis
| Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Agios Pharmaceuticals Technical Analysis
| Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||